诺诚健华（09969）于2026年6月26日发布翌日披露报表，公告显示，公司根据2024年人民币股股份激励计划首次授予部分第一归属期的归属结果，合计向2名董事、2名高级管理人员及70名激励对象发行人民币股份2,418,300股，约占本次变动前公司已发行股份（不含库藏股）总数的0.14%，每股发行价为人民币6.65元，募资总额约1,608.17万元人民币。
其中，香港交易所上市股份数量维持1,493,798,235股和2,486,000股库藏股不变；上海证券交易所科创板上市的人民币股份则由268,359,717股增至270,778,017股。此次变动后，公司合计已发行股本增至1,764,576,252股（不含库藏股），库藏股总数为2,486,000股。
诺诚健华在公告中确认已遵守所有适用的香港联合交易所有限公司证券上市规则及相关法律法规。该公告由公司董事会主席兼执行董事崔霁松博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.